TELA (TELA Bio) Moat Score: 3/10 (As of Jul. 07, 2026)


TELA TELA Bio Inc TELA
52 GF Score
Price $0.89
GF Value $1.66
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is TELA Bio Moat Score?

TELA Bio TELA +16.27% 52 Moat Score is 3 as of Jul. 07, 2026. GuruFocus rates TELA with a GF Score™ of 52/100 and a GF Value™ of $1.66 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 845 Medical Devices & Instruments companies, TELA Bio ranks better than 75.86% on this metric.

TELA Bio has the Moat Score of 3, which implies that the company might have No Moat - Very weak/transient advantages.

TELA Bio has No Moat: TELA Bio lacks significant market leadership or customer switching costs. While it may have some proprietary technology, it does not possess strong brand strength or durable cost advantages. Its competitive position is weak and transient.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes TELA Bio might have No Moat - Very weak/transient advantages.

TELA Bio  (NAS:TELA) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

TELA Bio Moat Score Related Terms

TELA vs NSPR, BDMD, PAVM: Moat Score Comparison

For the Medical Devices subindustry, TELA Bio's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TELA Bio Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, TELA Bio's Moat Score distribution charts can be found below:

* The bar in red indicates where TELA Bio's Moat Score falls into.


TELA
52GF Score
TELA Bio Inc TELA
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 3 mean?
TELA Bio (TELA) has a Moat Score of 3 as of Jul. 07, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, TELA Bio ranks #204 out of 845 companies in the Medical Devices & Instruments industry, placing it in the top 24.1%.
Is TELA Bio's Moat Score too high?
TELA Bio's current Moat Score is 3. Based on the distribution chart, TELA Bio ranks #204 out of 845 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, TELA Bio has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TELA Bio's Moat Score compare to NSPR and BDMD?
According to the Medical Devices & Instruments industry distribution chart, TELA Bio ranks #204 out of 845 companies for Moat Score. This places TELA Bio in the top 24% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. TELA Bio's current Moat Score is 3. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TELA Bio stock overvalued right now?
Based on GuruFocus' analysis, TELA Bio (TELA) is currently considered Possible Value Trap. The stock's GF Value™ is $1.66, compared to a current price of $0.89 — trading 46.2% below its estimated fair value. The current Moat Score is 3. TELA Bio's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For TELA Bio (TELA), the current Moat Score is 3 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TELA Bio (TELA) Overvalued in 2026?

Based on GuruFocus' analysis, TELA Bio stock appears to be undervalued. The current stock price of $0.89 is trading 46.2% below its estimated GF Value™ of $1.66. GuruFocus considers TELA Bio to be Possible Value Trap.

Key valuation signals for TELA:

  • Moat Score: 3
  • GF Value™: $1.66 vs. price of $0.89 (46.2% below fair value)
  • GF Score™: 52/100 with 4 warning signs

No single metric tells the full story. See the TELA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TELA Bio Business Description

Address 1 Great Valley Parkway, Suite 24, Malvern, PA, USA, 19355
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
52GF Score

Get the complete analysis for TELA

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.89
Price
$1.66
GF Value